US · NDRA
ENDRA Life Sciences Inc.
- Sector
- Healthcare · Medical - Diagnostics & Research
- Headquarters
- Ann Arbor, MI 48105-1570
- Website
- endrainc.com
Price · as of 2024-12-31
$4.95
Market cap 3.12M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | — | — |
| Intrinsic Value(DCF) | — | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | $0.00 | $0.00 | |||
| 2016 | $0.00 | $746.06 | |||
| 2017 | $107,100.00 | $43,351.55 | $4.03 | $0.00 | $612.19 |
| 2018 | $67,550.00 | $27,354.68 | $0.00 | $0.00 | $3,731.61 |
| 2019 | $38,850.00 | $15,550.17 | |||
| 2020 | $87,500.00 | ||||
| 2021 | $15,400.00 | ||||
| 2022 | $6,300.00 | ||||
| 2023 | $2,012.50 | ||||
| 2024 | $3.51 |
AI valuation
Our deep-learning model estimates ENDRA Life Sciences Inc.'s (NDRA) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- —
- Current price
- $4.95
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
—
— upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| NDRA | ENDRA Life Sciences Inc. | $4.95 | 3.12M | — | — | — | — | -0.34 | 1.54 | — | -0.12 | -0.46 | 1.54 | 0.00% | — | — | -280.02% | -690.14% | -205.38% | 0.23 | — | 5.67 | 5.34 | 0.25 | 7402.00% | — | -2260.00% | -188.25% | -12.23 | -473.18% | 0.13% | 0.00% | 5.35% | -0.12 | -0.17 | — | -38.53 |
| BBLG | Bone Biologics Corporatio… | $1.15 | 2.07M | — | — | — | — | -1.86 | 2.19 | — | 40.32 | — | 2.19 | 0.00% | — | — | -128.71% | -22020.98% | -108.23% | 0.00 | — | 10.22 | 8.80 | -31.03 | -8580.00% | — | -5683.00% | -53.95% | -10.92 | -21530.04% | 42.02% | -78.10% | 45.92% | -1.02 | -1.05 | — | -21.20 |
| BGMS | Bio Green Med Solution, I… | $0.98 | 1.89M | +2,199,316% | +3,759,305% | — | +3,987,072% | -0.07 | -0.38 | 19.24 | 0.19 | — | -0.38 | 100.00% | -27916.28% | -26074.42% | 1431.01% | 278.96% | -173.84% | 0.00 | — | 0.59 | 0.54 | 0.26 | -9219.00% | -8976.00% | -5043.00% | -965.78% | -1.27 | 198.63% | 0.00% | 0.00% | 0.00% | 0.19 | 0.29 | -53.71 | -160.64 |
| BNBX | BNB Plus Corp. | $0.71 | 910.41K | — | — | — | — | -0.10 | 0.67 | 0.73 | -0.01 | — | 0.67 | 39.26% | -750.92% | -709.46% | — | — | — | 0.08 | — | 0.91 | 0.77 | 0.09 | — | — | — | -826.25% | -5.08 | — | 0.00% | 0.00% | 0.00% | 0.00 | -0.01 | 0.04 | -130.76 |
| DHAI | DIH Holding US, Inc. | $0.00 | 5.23K | +1,170,700% | +87,500% | — | — | -903.76 | -211.15 | 124.73 | -1104.70 | — | -211.15 | 51.24% | -7.74% | -13.80% | 24.90% | 20.72% | -27.77% | -0.32 | -15.34 | 0.49 | 0.12 | -1.41 | -2412.00% | -250.00% | -19379.00% | -0.06% | -0.10 | 19.94% | 0.00% | 0.00% | 0.03% | -1614.12 | -1677.58 | 124.89 | 72.12 |
| GCTK | GlucoTrack, Inc. | $1.55 | 879.56K | — | — | — | — | -0.36 | -0.63 | — | -0.13 | — | -0.63 | 0.00% | — | — | 461.02% | 149.59% | -417.03% | -0.02 | -24.95 | 4.52 | 4.41 | 0.24 | -25864.00% | — | 9204.00% | -152.95% | -9.80 | 129.51% | 0.00% | 0.00% | 12.80% | -0.20 | -0.23 | — | -38.18 |
| HSCS | HeartSciences Inc. | $2.79 | 6.25M | +699% | -40% | — | +21,742% | -0.45 | 19.02 | 897.28 | -0.71 | — | -2.77 | -2884.71% | -192013.13% | -201499.52% | -233.04% | -360.16% | -127.72% | 14.55 | -16.69 | 0.59 | 0.30 | -0.23 | -5016.00% | -7661.00% | 2014.00% | -190.70% | -2.00 | -320.95% | 0.00% | 0.00% | 0.00% | -0.69 | -0.78 | 1331.10 | -31.62 |
| ISPC | iSpecimen Inc. | $0.25 | 1.39M | +15,728% | +124% | — | — | -0.08 | 0.30 | 0.11 | 0.04 | — | -0.50 | 42.93% | -136.99% | -134.51% | -191.51% | -381.28% | -99.31% | 0.09 | -57.84 | 0.62 | 0.58 | 0.12 | -2839.00% | -642.00% | -2115.00% | -830.12% | -1.43 | -249.24% | 0.00% | 0.00% | 0.00% | 0.04 | 0.07 | -0.06 | -14.44 |
| MOVE | Movano Inc. | $11.40 | 8.65M | — | — | — | — | -90.32 | 291.38 | 2115.60 | -88.77 | — | 291.38 | -196.84% | -2391.12% | -2342.25% | -439.23% | 1722.15% | -228.79% | 0.03 | — | 3.02 | 2.31 | 0.32 | -3810.00% | — | -1410.00% | -1.05% | -6.54 | 1602.63% | 0.00% | 0.00% | 0.08% | -88.16 | -94.73 | 2107.98 | 299.75 |
| NAOV | NanoVibronix, Inc. | $2.26 | 1.8M | +62,596% | +597% | — | — | -2.87 | 16.95 | 4.15 | -2.71 | — | 16.95 | 58.95% | -140.03% | -144.84% | -160.56% | -1021.97% | -71.92% | 0.19 | -26.53 | 1.22 | 0.37 | 0.17 | -3524.00% | 1205.00% | -3009.00% | -23.70% | -0.92 | -718.69% | 0.00% | 0.00% | 0.00% | -2.79 | -3.97 | 3.91 | -27.16 |
| VERO | Venus Concept Inc. | $0.31 | 576.33K | +37,326% | +290% | — | +132,842% | -0.05 | 0.91 | 0.03 | -1.14 | -0.01 | -0.83 | 68.34% | -41.93% | -72.49% | 806.37% | -52.93% | -58.05% | 18.16 | -3.55 | 1.60 | 0.78 | -1.08 | 86901.00% | -1509.00% | -1376.00% | -520.15% | -0.37 | -22.07% | 0.00% | 0.00% | 1652.41% | -1.50 | -3.66 | 0.63 | -6.37 |
About ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
- CEO
- Alexander Y. Tokman
- Employees
- 21
- Beta
- -0.04
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $4.95) − 1 = — (DCF, example).